Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DOCS.L Stock Summary
Top 10 Correlated ETFs
DOCS.L
In the News
DOCS.L Financial details
Company Rating
-
Market Cap
1.33B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.06
Dividend %
4.32%
Employees
2.23K
Optionable
No
Shortable
Yes
Earnings
01 Jun 2023
P/E
7.47
Forward P/E
-
PEG
-
P/S
1.49
P/B
4.12
P/C
-
P/FCF
8.49
Quick Ratio
1.47
Current Ratio
2.86
Debt / Equity
1.83
LT Debt / Equity
1.18
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
400%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
21.11%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-14.52%
SMA50
-35.82%
SMA100
-45.03%
Inst Own
-
Inst Trans
-
ROA
21%
ROE
76%
ROC
0.32%
Gross Margin
64%
Oper. Margin
25%
Profit Margin
20%
Payout
7%
Shs Outstand
1B
Shs Float
548.86M
-
-
-
-
Target Price
-
52W Range
128.3-295.212
52W High
-54.81%
52W Low
+4.14%
RSI
35.48
Rel Volume
0.49
Avg Volume
3.94M
Volume
1.93M
Perf Week
3.9%
Perf Month
-13.16%
Perf Quarter
-42.19%
Perf Half Y
-50.96%
-
-
-
-
Beta
0.029898
-
-
Volatility
1.2%, 10.37%
Prev Close
-1.04%
Price
133.3
Change
2.54%
DOCS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
---|---|---|---|---|---|---|
Revenue per share | 0.35 | 0.45 | 0.67 | 0.77 | 0.91 | |
Net income per share | -0.01 | 0.02 | 0.07 | 0.04 | 0.18 | |
Operating cash flow per share | 0.05 | 0.06 | 0.12 | 0.16 | 0.18 | |
Free cash flow per share | 0.03 | 0.04 | 0.1 | 0.14 | 0.16 | |
Cash per share | 0.09 | 0.06 | 0.12 | 0.11 | 0.23 | |
Book value per share | -0.03 | -0.01 | 0.07 | 0.15 | 0.33 | |
Tangible book value per share | -0.28 | -0.26 | -0.19 | -0.11 | 0.07 | |
Share holders equity per share | -0.03 | -0.01 | 0.07 | 0.15 | 0.33 | |
Interest debt per share | 0.12 | 0.11 | 0.22 | 0.41 | 0.41 | |
Market cap | 4.5B | 4.5B | 4.5B | 4.53B | 2.39B | |
Enterprise value | 4.49B | 4.52B | 4.57B | 4.78B | 2.55B | |
P/E ratio | -789.47 | 261.63 | 60.16 | 126.95 | 13.18 | |
Price to sales ratio | 12.91 | 9.9 | 6.69 | 5.86 | 2.63 | |
POCF ratio | 97.83 | 80.36 | 37.07 | 28.29 | 12.95 | |
PFCF ratio | 152.03 | 115.68 | 45.23 | 32.01 | 14.98 | |
P/B Ratio | -153.06 | -535.71 | 63.83 | 30.07 | 7.28 | |
PTB ratio | -153.06 | -535.71 | 63.83 | 30.07 | 7.28 | |
EV to sales | 12.88 | 9.94 | 6.79 | 6.19 | 2.81 | |
Enterprise value over EBITDA | 97.62 | 58.04 | 26.67 | 33.09 | 9.64 | |
EV to operating cash flow | 97.62 | 80.64 | 37.61 | 29.87 | 13.85 | |
EV to free cash flow | 151.7 | 116.09 | 45.88 | 33.79 | 16.02 | |
Earnings yield | 0 | 0 | 0.02 | 0.01 | 0.08 | |
Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.03 | 0.07 | |
Debt to equity | -16.16 | -54.6 | 8.31 | 3.33 | 1.62 | |
Debt to assets | 1.07 | 1.02 | 0.89 | 0.77 | 0.62 | |
Net debt to EBITDA | -0.21 | 0.2 | 0.38 | 1.75 | 0.63 | |
Current ratio | 3.04 | 2.57 | 2.12 | 1.8 | 2.86 | |
Interest coverage | 1.04 | 1.78 | 3.5 | 2.91 | 16.38 | |
Income quality | -8.07 | 3.26 | 1.62 | 4.49 | 1.02 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
Payout ratio | 0 | 0 | 0 | 0 | 0.07 | |
Sales general and administrative to revenue | 0.42 | 0.42 | 0.39 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.56 | 0.56 | 0.39 | 0.4 | 0.31 | |
Capex to operating cash flow | -0.36 | -0.31 | -0.18 | -0.12 | -0.14 | |
Capex to revenue | -0.05 | -0.04 | -0.03 | -0.02 | -0.03 | |
Capex to depreciation | -2.52 | -1.61 | -0.74 | -0.53 | -0.68 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
Graham number | 0.06 | 0.06 | 0.34 | 0.35 | 1.16 | |
ROIC | -1.29 | 0.13 | 0.27 | 0.15 | 0.55 | |
Return on tangible assets | -0.03 | 0.09 | 0.19 | 0.09 | 0.3 | |
Graham Net | -0.37 | -0.37 | -0.42 | -0.34 | -0.24 | |
Working capital | 113.7M | 101M | 146.5M | 122.5M | 288.6M | |
Tangible asset value | -277.9M | -260.2M | -186.7M | -110.1M | 66.1M | |
Net current asset value | -305.9M | -293.1M | -308.8M | -227.3M | -87.3M | |
Invested capital | -2.61 | -8.85 | 2.59 | 2.43 | 1.2 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 19.8M | 26.7M | 43M | 52.5M | |
Average inventory | 0 | 46.85M | 71.95M | 95.75M | 112.25M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 44 | 37.67 | 45.04 | 63.47 | 58.05 | |
Days of inventory on hand | 89.34 | 101.51 | 121.35 | 122.47 | 136.25 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 8.3 | 9.69 | 8.1 | 5.75 | 6.29 | |
Inventory turnover | 4.09 | 3.6 | 3.01 | 2.98 | 2.68 | |
ROE | 0.19 | -2.05 | 1.06 | 0.24 | 0.55 | |
Capex per share | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q2
Metric | History | 2020-09-30 | 2021-03-31 | 2021-09-30 | 2022-03-31 | 2022-09-30 |
---|---|---|---|---|---|---|
Revenue per share | 0 | 0 | 0 | 0 | 0 | |
Net income per share | 0 | 0 | 0 | 0 | 0 | |
Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
Cash per share | 0 | 0 | 0 | 0 | 0 | |
Book value per share | 0 | 0 | 0 | 0 | 0 | |
Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
Market cap | 0 | 0 | 0 | 0 | 0 | |
Enterprise value | 27.9M | 252.8M | 270.9M | 165.8M | 302.7M | |
P/E ratio | 0 | 0 | 0 | 0 | 0 | |
Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
POCF ratio | 0 | 0 | 0 | 0 | 0 | |
PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
PTB ratio | 0 | 0 | 0 | 0 | 0 | |
EV to sales | 0 | 0 | 0 | 0 | 0 | |
Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
Earnings yield | 0 | 0 | 0 | 0 | 0 | |
Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
Debt to equity | 6.48 | 3.33 | 2.49 | 1.62 | 1.83 | |
Debt to assets | 0.87 | 0.77 | 0.71 | 0.62 | 0.65 | |
Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
Current ratio | 2.03 | 1.8 | 2.24 | 2.86 | 2.39 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 0 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.35 | 0.4 | 0.37 | 0.31 | 0.27 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 0 | 0 | 0 | 0 | 0 | |
ROIC | 0 | 0 | 0 | 0 | 0 | |
Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
Graham Net | 0 | 0 | 0 | 0 | 0 | |
Working capital | 189.1M | 122.5M | 173.8M | 288.6M | 304.7M | |
Tangible asset value | -159.4M | -110.1M | -57.7M | 66.1M | 81.4M | |
Net current asset value | -277.8M | -227.3M | -192M | -87.3M | -111.2M | |
Invested capital | 1.74 | 2.43 | 1.89 | 1.2 | 1.26 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 58.45M | 68.05M | 49.3M | 49.2M | 79.05M | |
Average inventory | 109M | 114.75M | 110.65M | 121.4M | 192.2M | |
Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
Payables turnover | 0 | 0 | 0 | 0 | 0 | |
Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
ROE | 0 | 0 | 0 | 0 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
DOCS.L Frequently Asked Questions
What is Dr. Martens plc stock symbol ?
Dr. Martens plc is a GB stock and trading under the symbol DOCS.L
What is Dr. Martens plc stock quote today ?
Dr. Martens plc stock price is $133.3 today.
Is Dr. Martens plc stock public?
Yes, Dr. Martens plc is a publicly traded company.